Rekvina Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Rekvina Laboratories Ltd. on BSE

Search Inside the pdf :

14 Nov 2025, 05:12PM

Company Update

Rekvina Laboratories Ltd - 526075 - Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure …

BSE India

The Paid up capital of the Company is less than Rs. 10/-(Ten) Crores and Net Worth of the Company is less than Rs. 25 /- (Twenty-Five)Crores as on 31.03.2025, so there is non-applicability of Reg 23(9) of SEBI (Listing Obligation and Disclosure Requirements) (Amendment) Regulation , 2018.

pdf

Rekvina Laboratories Ltd.

14 Nov 2025, 05:06PM

Result

Rekvina Laboratories Ltd - 526075 - Standalone Financial Result For The Period Ended On 30 September …

BSE India

QTR-2 FINANCIAL RESULT

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.20	0.00	0.00	-	-
Operating Profit Qtr	-0.03	-0.04	-0.07	25.0%	57.1%
Net Profit Qtr	-0.03	-0.04	-0.07	25.0%	57.1%
Earning Per Share Adjusted latest Qtr	-0.06	-0.06	-0.11	0.0%	45.5%

* Standalone data

Detailed Results

Rekvina Laboratories Ltd.

14 Nov 2025, 04:52PM

Board Meeting

Rekvina Laboratories Ltd - 526075 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Dear Sir/Madam, Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 14th November, 2025 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2025. The meeting of the Board of Directors commenced at 03:30 P.M. and concluded at 04:25 P.M. This is for your information and record.

pdf

Rekvina Laboratories Ltd.

05 Nov 2025

Board Meeting

Rekvina Laboratories Ltd - 526075 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th November, 2025, inter alia; 1. To consider and approve Un-audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter and Half Year ended on 30th September, 2025. 2. Any other agendas as may be considered necessary with the permission of the chair. Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Company has intimated its 'designated persons' regarding the closure of the Trading Window for trading in the Company's equity shares from October 01, 2025 till the expiry of 48 hours from the date of said financial results are made public.

pdf

Rekvina Laboratories Ltd.

13 Oct 2025

Company Update

Rekvina Laboratories Ltd - 526075 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018, please find enclosed herewith copy of Certificate received from M/s. Purva Sharegistry India Pvt. Ltd., the Registrar and Share Transfer Agent of the Company for the period from 1st July, 2025 to 30th September, 2025.

pdf

Rekvina Laboratories Ltd.

06 Oct 2025

Company Update

Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Appointment of Mr. Prateek Jain (DIN: 08611660) as an Additional Non-Executive Independent Director of the Company, pursuant to the Provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf